Lack of tyramine pressor response effect with oral CX157: A specific reversible MAOI-Reference-Cited by-同舟云学术

Lack of tyramine pressor response effect with oral CX157: A specific reversible MAOI

Published:2013-10-22 Issue:1 Volume:3 Page:4-12
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:

Author:

Burch Daniel¹,Asgharnejad Mahnaz¹,Gerson William²,Fielding Robert M.³,Azzaro Albert J.⁴

Affiliation:

1. CeNeRx BioPharma, Inc.; Cary NC USA

2. Segal Institute for Clinical Research; Corporate Headquarters; North Miami FL USA

3. Biologistic Services; Boulder CO USA

4. AJA PharmaServices; Tarpon Springs FL USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.61/fullpdf

Reference39 articles.

1. Monoamine oxidase: From physiology and pathology to the design and clinical application of reversible inhibitors;Strolin Benedetti;Adv Drug Res.,1992

2. Monoamine oxidase: From genes to behavior;Shih;Annu Rev Neurosci.,1999

3. The involvement of intestinal monoamine oxidase in the transport and metabolism of tyramine;Hasan;J Neural Transm Suppl.,1988

4. Monoamine oxidase inhibitors and the cheese effect;Anderson;Neurochem Res.,1993

5. An outpatient evaluation of phenelzine and imipramine;Davidson;J Clin Psychiatry.,1987

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities;Current Drug Targets;2016-12-02

2. Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression;CNS Spectrums;2012-08-06